News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Solazyme, Inc. Proposes $100 Million IPO and Nasdaq Global Market Listing


3/14/2011 10:47:12 AM

GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--On March 11, 2011, one of Keating Capital, Inc.’s portfolio companies, Solazyme, Inc., filed an S-1 registration statement to go public through a $100 million initial public offering of its common stock. Solazyme intends to list its shares on the Nasdaq Global Market under the symbol "SZYM." Morgan Stanley and Goldman, Sachs & Co. are acting as lead underwriters.

Read at BioSpace.com
Read at Xconomy
Read at Private Equity Hub

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES